CLINICAL_TRIALS
trial_result
· 2015-01-26
Clinical Trial Update: Treatment of Adult Ph+ LAL With BMS-354825 [Phase 2]
Summary
This Phase 2 trial evaluates dasatinib (BMS-354825) in adults with Philadelphia chromosome–positive acute lymphoblastic leukemia; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Lymphoblastic Leukemia, Acute | Phase 2 | Status: COMPLETED | Results posted: 2015-01-26